Table 2.
Number of patients with data available | Patients included (n = 501) | |
---|---|---|
Location of the patient before ICU admission | 501 | |
Acute facility care | 290 (58%) | |
Home | 172 (34%) | |
Chronic facility care | 11 (2%) | |
Supervised residence setting | 8 (3%) | |
Other | 20 (4%) | |
Primary ICU diagnosis | 498 | |
Septic shock | 78 (15.7%) | |
Non-septic shock | 22 (4.4%) | |
Resuscitated cardiac arrest | 52 (10.4%) | |
Acute on chronic respiratory failure | 64 (12.9%) | |
Acute respiratory failure | 149 (29.9%) | |
Acute kidney injury and metabolic disorders | 11 (2.2%) | |
Neurological disorder | 51 (10.2%) | |
Post-surgery | 26 (5.2%) | |
Drug overdose | 5 (1%) | |
Trauma | 7 (1.4%) | |
Other | 33 (6.6%) | |
Admission SOFA, m ± sd | 501 | 7.0 ± 3.7 |
Admission SAPSII, m ± sd | 501 | 54 ± 17 |
Type of mechanical ventilation, n (%) | 489 | |
Invasive only | 290 (59.3%) | |
Non-invasive only | 98 (20.0%) | |
Combined | 101 (20.7%) | |
Total length of mechanical ventilation (days), m ± sd | 463 | 7.5 ± 10.0 |
Med (IQR) | 4 (2–10) | |
Renal replacement therapy requirement | 498 | 70 (14.1%) |
Total length of renal replacement therapy, m ± sd | 70 | 7.6 ± 9.3 |
Med (IQR) | 4 (1–11) | |
Vasopressor requirement | 497 | 252 (50.7%) |
Total length of vasopressor infusion (days), m ± sd | 251 | 4.4 ± 6.2 |
Med (IQR) | 2 (1–5) | |
ICU length of stay (days), m ± sd | 499 | 10.5 ± 13.8 |
Med (IQR) | 2 (1–5) | |
Hospital length of stay (days), m ± sd | 499 | 20.2 ± 23.3 |
Med (IQR) | 14 (7–26) | |
ICU mortality | 499 | 108 (21.6%) |
Hospital mortality | 499 | 130 (26.0%) |
Limitation of life sustaining therapies, n (%) | 447 | 135 (30.2%) |
Data are n (%), mean (m) ± standard deviation (sd) or median (med) with interquartile range (IQR). ICU, intensive care unit, SAPS, Simplified Acute Physiology Score, SOFA, Sequential Organ Failure Assessment